Cover Image
Market Research Report

Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Published by GlobalData Product code 351353
Published Content info 382 Pages
Delivery time: 1-2 business days
Price
Back to Top
Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
Published: December 15, 2019 Content info: 382 Pages
Description

GlobalData's Medical Devices sector report, "Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Auto-Immune Diseases Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Auto-Immune Diseases Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Auto-Immune Diseases Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0840EPD

Table of Contents

1. Table of Contents

  • 1.1 List of Tables 10
  • 1.2 List of Figures 18

2 Introduction 20

  • 2.1 Auto-Immune Diseases Overview 20

3 Products under Development 21

  • 3.1 Auto-Immune Diseases - Pipeline Products by Stage of Development 21
  • 3.2 Auto-Immune Diseases - Pipeline Products by Territory 22
  • 3.3 Auto-Immune Diseases - Pipeline Products by Regulatory Path 23
  • 3.4 Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 24
  • 3.5 Auto-Immune Diseases - Ongoing Clinical Trials 25

4 Auto-Immune Diseases - Pipeline Products under Development by Companies 26

  • 4.1 Auto-Immune Diseases Companies - Pipeline Products by Stage of Development 26
  • 4.2 Auto-Immune Diseases - Pipeline Products by Stage of Development 30

5 Auto-Immune Diseases Companies and Product Overview 36

6 Auto-Immune Diseases- Recent Developments 202

7 Appendix 371

List of Tables

  • Table 1: Auto-Immune Diseases - Pipeline Products by Stage of Development 22
  • Table 2: Auto-Immune Diseases - Pipeline Products by Territory 23
  • Table 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path 24
  • Table 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 25
  • Table 5: Auto-Immune Diseases - Ongoing Clinical Trials 26
  • Table 6: Auto-Immune Diseases Companies - Pipeline Products by Stage of Development 27
  • Table 7: Auto-Immune Diseases - Pipeline Products by Stage of Development 31
  • Table 8: Aarhus University Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 9: Biomarker Test - Multiple Sclerosis - Product Status 37
  • Table 10: Biomarker Test - Multiple Sclerosis - Product Description 37
  • Table 11: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 12: Non-Invasive Diagnostic Test - Celiac Disease - Product Status 38
  • Table 13: Non-Invasive Diagnostic Test - Celiac Disease - Product Description 38
  • Table 14: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 15: Biomarker Based Assay - Systemic Sclerosis - Product Status 39
  • Table 16: Biomarker Based Assay - Systemic Sclerosis - Product Description 39
  • Table 17: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Status 40
  • Table 18: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Description 40
  • Table 19: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 20: AIMS System - Cardiolipin IgG Test - Product Status 41
  • Table 21: AIMS System - Cardiolipin IgG Test - Product Description 41
  • Table 22: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Status 42
  • Table 23: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Description 42
  • Table 24: Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 25: Diagnostic Assay - Neuromyelitis Optica - Product Status 43
  • Table 26: Diagnostic Assay - Neuromyelitis Optica - Product Description 43
  • Table 27: Diagnostic Assay - Paraneoplastic Disease - Product Status 44
  • Table 28: Diagnostic Assay - Paraneoplastic Disease - Product Description 44
  • Table 29: apDia nv Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 30: Diagnostic Test - MS (Multiple Sclerosis) - Product Status 45
  • Table 31: Diagnostic Test - MS (Multiple Sclerosis) - Product Description 45
  • Table 32: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 33: Anti-Squalene Antibody Assay - Product Status 46
  • Table 34: Anti-Squalene Antibody Assay - Product Description 46
  • Table 35: Autoimmune Disease Virus Assay - Graves' Disease - Product Status 47
  • Table 36: Autoimmune Disease Virus Assay - Graves' Disease - Product Description 47
  • Table 37: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Status 47
  • Table 38: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Description 48
  • Table 39: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Status 48
  • Table 40: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Description 48
  • Table 41: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Status 49
  • Table 42: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Description 49
  • Table 43: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 44: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Status 50
  • Table 45: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Description 50
  • Table 46: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 47: Diagnostic Assay - Multiple Sclerosis - Product Status 51
  • Table 48: Diagnostic Assay - Multiple Sclerosis - Product Description 51
  • Table 49: Biogen Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 50: Companion Diagnostic Test - Sjogren's Syndrome - Product Status 52
  • Table 51: Companion Diagnostic Test - Sjogren's Syndrome - Product Description 52
  • Table 52: Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 53: ELISA DELIAC GFD - Product Status 53
  • Table 54: ELISA DELIAC GFD - Product Description 53
  • Table 55: IVYLISA DGP8 - Product Status 54

List of Figures

  • Figure 1: Auto-Immune Diseases - Pipeline Products by Stage of Development 22
  • Figure 2: Auto-Immune Diseases - Pipeline Products by Territory 23
  • Figure 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path 24
  • Figure 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 25
  • Figure 5: Auto-Immune Diseases - Ongoing Clinical Trials 26
Back to Top